Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACHL

Achilles Therapeutics (ACHL) Stock Price, News & Analysis

Achilles Therapeutics logo

About Achilles Therapeutics Stock (NASDAQ:ACHL)

Advanced Chart

Key Stats

Today's Range
$1.48
$1.48
50-Day Range
$1.48
$1.48
52-Week Range
$0.63
$1.51
Volume
N/A
Average Volume
719,003 shs
Market Capitalization
$60.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ACHL Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

ACHL Stock Analysis - Frequently Asked Questions

Achilles Therapeutics plc (NASDAQ:ACHL) issued its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.41) EPS for the quarter, hitting analysts' consensus estimates of ($0.41).

Achilles Therapeutics (ACHL) raised $176 million in an IPO on Wednesday, March 31st 2021. The company issued 9,800,000 shares at $17.00-$19.00 per share. JPMorgan, BofA Securities, Piper Sandler, Chardan, Oppenheimer & Co. and Kempen & Co. served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Achilles Therapeutics investors own include Digital Turbine (APPS), Aquestive Therapeutics (AQST), CRISPR Therapeutics (CRSP), ChargePoint (CHPT) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/14/2024
Today
7/15/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ACHL
CIK
1830749
Fax
N/A
Employees
250
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$69.67 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-54.45%
Return on Assets
-47.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.04
Quick Ratio
6.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.49 per share
Price / Book
0.42

Miscellaneous

Outstanding Shares
41,100,000
Free Float
38,889,000
Market Cap
$60.83 million
Optionable
Not Optionable
Beta
1.25
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:ACHL) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners